Rampart Bioscience
Virginia Le Verche, PhD, serves as the Director of R&D Portfolio & Strategic Initiatives at Rampart Bioscience since May 2022. Virginia co-founded INDuarte Consulting, LLC in January 2019, specializing in strategic and regulatory consulting for cell and gene therapy, with a mission to expedite the development of FDA-approved products. Prior experience includes directing research program coordination at City of Hope, managing preclinical and clinical project initiatives, and serving as a scientist at the SMA Foundation, focusing on therapeutics for Spinal Muscular Atrophy. Virginia's academic background includes research roles at Columbia University Medical Center, with notable contributions to ALS studies, and a Ph.D. from Pierre and Marie Curie University in Cellular and Molecular Neurobiology. Virginia's educational credentials are complemented by certifications in business and management from Columbia University.
This person is not in any teams
This person is not in any offices
Rampart Bioscience
Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines — including gene delivery, protein sciences and clinical translation — to leap beyond the limitations of current gene therapies. Powered by our novel non-viral DNA delivery system, we are on a path to achieve higher standards for potency, durability, redosability and safety. Together, we are working to reshape the treatment landscape for people in dire need of better options.